福安药业(300194.SZ)子公司收到一项化学原料药上市申请批准

Core Viewpoint - Fuan Pharmaceutical's subsidiary, Ningbo Tianheng Pharmaceutical, has received approval from the National Medical Products Administration for the market launch of the chemical raw material drug, Morinazole, which is used to treat infections caused by anaerobic bacteria [1] Company Summary - Fuan Pharmaceutical's subsidiary, Tianheng Pharmaceutical, is focused on the production of chemical raw materials [1] - The approved drug, Morinazole, is indicated for the treatment of infectious diseases such as lower respiratory tract infections, pelvic inflammatory disease, and sepsis [1]